Open Access
Volume 6, 2020
Article Number 37
Number of page(s) 4
Section Hip
Published online 19 September 2020
  1. CDC (2013) Monitoring selected national HIV prevention and care objectives by using HIV surveillance data – United States and 6 U.S. dependent areas – 2011. In: HIV Surveillance Supplemental Report. [Google Scholar]
  2. Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H (2014) Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol 61(1), S45–S57. [CrossRef] [PubMed] [Google Scholar]
  3. Mandorfer M, Schwabl P, Steiner S, Reiberger T, Peck-Radosavljevic M (2016) Advances in the management of HIV/HCV coinfection. Hepatol Int 10(3), 424–435. [CrossRef] [PubMed] [Google Scholar]
  4. Marcus JL, Chao CR, Leyden WA, et al. (2016) Narrowing the gap in life expectancy between HIV-infected and HIV-uninfected individuals with access to care. J Acquir Immune Defic Syndr 73(1), 39–46. [PubMed] [Google Scholar]
  5. Rosen H (2011) Chronic hepatitis C infection. NEJM 364, 2429–2438. [CrossRef] [Google Scholar]
  6. Best MJ, Buller LT, Klika AK, Barsoum WK (2015) Increase in perioperative complications following primary total hip and knee arthroplasty in patients with hepatitis C without cirrhosis. J Arthroplasty 30(4), 663–668. [CrossRef] [PubMed] [Google Scholar]
  7. Orozco F, Post ZD, Baxi O, Miller A, Ong A (2014) Fibrosis in hepatitis c patients predicts complications after elective total joint arthroplasty. J Arthroplasty 29(1), 7–10. [CrossRef] [PubMed] [Google Scholar]
  8. Issa K, Boylan MR, Naziri Q, Perfetti DC, Maheshwari AV, Mont MA (2014) The impact of hepatitis c on short-term outcomes of total joint arthroplasty. J Bone Jt Surg – Am 97(23), 1952–1957. [CrossRef] [Google Scholar]
  9. Boylan MR, Basu N, Naziri Q, Issa K, Maheshwari AV, Mont MA (2015) Does HIV infection increase the risk of short-term adverse outcomes following total knee arthroplasty? J Arthroplasty 30(9), 1629–1632. [CrossRef] [PubMed] [Google Scholar]
  10. Naziri Q, Boylan MR, Issa K, Jones LC, Khanuja HS, Mont MA (2015) Does HIV infection increase the risk of perioperative complications after THA? A nationwide database study. Clin Orthop Relat Res 473(2), 581–586. [CrossRef] [PubMed] [Google Scholar]
  11. Lin CA, Kuo AC, Takemoto S (2013) Comorbidities and perioperative complications in HIV-positive patients undergoing primary total hip and knee arthroplasty. J Bone Jt Surg – Ser A 95(11), 1028–1036. [CrossRef] [PubMed] [Google Scholar]
  12. Rockstroh J, Hardy W (2016) Current treatment options for hepatitis C patients co-infected with HIV. Exp Rev Gastroenterol Hepatol 10, 689–695. [CrossRef] [Google Scholar]
  13. Sulkowski MS (2016) HCV-HIV co-infected patients: No longer a “special” population? Liver Int 36(November 2015), 43–46. [CrossRef] [PubMed] [Google Scholar]
  14. Alter MJ (2006) Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 44(Suppl. 1), 6–9. [Google Scholar]
  15. Rossetti B, Bai F, Tavelli A, et al. (2018) Evolution of the prevalence of hepatitis C virus infection and hepatitis C virus genotype distribution in human immunodeficiency virus-infected patients in Italy between 1997 and 2015. Clin Microbiol Infect 24(4), 422–427. [CrossRef] [PubMed] [Google Scholar]
  16. Boesecke C, Grint D, Soriano V, et al. (2015) Hepatitis C seroconversions in HIV infection across Europe: Which regions and patient groups are affected? Liver Int 35(11), 2384–2391. [CrossRef] [PubMed] [Google Scholar]
  17. Quan VM, Go V, Van Nam L, et al. (2014) Risks for HIV, HBV, and HCV infections among male injection drug users in northern Vietnam: A case-control study. Bone 23(1), 1–7. [Google Scholar]
  18. Garten RJ, Lai S, Zhang J, et al. (2004) Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. Int J Epidemiol 33(1), 182–188. [CrossRef] [PubMed] [Google Scholar]
  19. Kildow BJ, Politzer CS, DiLallo M, Bolognesi MP, Seyler TM (2018) Short and long-term postoperative complications following total joint arthroplasty in patients with human immunodeficiency virus, hepatitis B, or hepatitis C. J Arthroplasty 33(7), S86–S92.e1. [CrossRef] [PubMed] [Google Scholar]
  20. Grau L, Zachwieja E, Summers SH, et al. (2018) Hepatitis C is an independent risk factor for perioperative complications and nonroutine discharge in patients treated surgically for hip fractures. J Orthop Trauma 32(11), 565–572. [CrossRef] [PubMed] [Google Scholar]
  21. Maharaj Z, Pietrzak JRT, Sikhauli N, Van De Jagt D, Mokete L (2020) The seroprevalence of HIV in patients undergoing lower limb total joint arthroplasty (TJA) in South Africa. Sicot-J 6, 3. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  22. National Joint Registry (NJR) Editorial Board (2018) NJR 15th Annual Report. [Google Scholar]
  23. Lo V, Iii R, Volk J, et al. (2013) Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/HIV coinfection. NIH Pub Access 56(5), 1688–1698. [Google Scholar]
  24. Mahure SA, Bosco JA, Slover JD, Vigdorchik JM, Iorio R, Schwarzkopf R (2017) Coinfection with hepatitis C and HIV is a risk factor for poor outcomes after total knee arthroplasty. JBJS Open Access 2(3), e0009. [CrossRef] [Google Scholar]
  25. Mahure SA, Bosco JA, Slover JD, Vigdorchik J, Iorio R, Schwarzkopf R (2018) Risk of complications after THA increases among patients who are coinfected with HIV and hepatitis C. Clin Orthop Relat Res 476(2), 356–369. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.